Ferris R - Search Results

1

De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies.

Mehanna H, Rischin D, Wong SJ, Gregoire V, Ferris R, Waldron J, Le QT, Forster M, Gillison M, Laskar S, Tahara M, Psyrri A, Vermorken J, Porceddu S. Mehanna H, et al. Among authors: ferris r. J Clin Oncol. 2020 Aug 1;38(22):2552-2557. doi: 10.1200/JCO.20.00056. Epub 2020 Jun 4. J Clin Oncol. 2020. PMID: 32496903 Free PMC article. Review.

2

Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.

Sirianni N, Wang J, Ferris RL. Sirianni N, et al. Oral Oncol. 2005 Apr;41(4):423-8. doi: 10.1016/j.oraloncology.2004.11.003. Oral Oncol. 2005. PMID: 15792615

3

Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.

Ferris RL, Whiteside TL, Ferrone S. Ferris RL, et al. Clin Cancer Res. 2006 Jul 1;12(13):3890-5. doi: 10.1158/1078-0432.CCR-05-2750. Clin Cancer Res. 2006. PMID: 16818683 Review.

4

Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.

Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, Winans M, Bigbee W, Siegfried J, Lokshin A, Ferris RL. Linkov F, et al. Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):102-7. doi: 10.1158/1055-9965.EPI-06-0602. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17220337

5

Long-term outcomes with concurrent carboplatin, paclitaxel and radiation therapy for locally advanced, inoperable head and neck cancer.

Agarwala SS, Cano E, Heron DE, Johnson J, Myers E, Sandulache V, Bahri S, Ferris R, Wang Y, Argiris A. Agarwala SS, et al. Among authors: ferris r. Ann Oncol. 2007 Jul;18(7):1224-9. doi: 10.1093/annonc/mdm088. Ann Oncol. 2007. PMID: 17675395 Free article. Clinical Trial.

6

Head and neck cancer immunotherapy: clinical evaluation.

Leibowitz MS, Nayak JV, Ferris RL. Leibowitz MS, et al. Curr Oncol Rep. 2008 Mar;10(2):162-9. doi: 10.1007/s11912-008-0025-8. Curr Oncol Rep. 2008. PMID: 18377830 Review.

7

Head and neck cancer.

Argiris A, Karamouzis MV, Raben D, Ferris RL. Argiris A, et al. Lancet. 2008 May 17;371(9625):1695-709. doi: 10.1016/S0140-6736(08)60728-X. Lancet. 2008. PMID: 18486742 Free PMC article. Review.

8

Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies.

Lee SC, López-Albaitero A, Ferris RL. Lee SC, et al. Curr Oncol Rep. 2009 Mar;11(2):156-62. doi: 10.1007/s11912-009-0023-5. Curr Oncol Rep. 2009. PMID: 19216848 Review.

9

Immunotherapy for head and neck cancer.

Davidson HC, Leibowitz MS, Lopez-Albaitero A, Ferris RL. Davidson HC, et al. Oral Oncol. 2009 Sep;45(9):747-51. doi: 10.1016/j.oraloncology.2009.02.009. Epub 2009 May 12. Oral Oncol. 2009. PMID: 19442565 Free PMC article. Review.

10

Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck cancers.

Gokhale AS, McLaughlin BT, Flickinger JC, Beriwal S, Heron DE, Ferris RL, Johnson J, Gibson MK, Argiris A, Smith RP. Gokhale AS, et al. Among authors: ferris rl. Ann Oncol. 2010 Jan;21(1):145-51. doi: 10.1093/annonc/mdp268. Epub 2009 Jul 14. Ann Oncol. 2010. PMID: 19602566 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

712 results

Search Page